Global food and beverage giants are scrambling to outbid each other for GlaxoSmithKline’s Horlick health nutrition business amid a review announced by the UK-based company, including options to sell some nutrition brands such as Horlicks.
Coca-Cola, Nestle and Kraft Heinz are said to be among the companies bidding for the 145 year old brand, with Coca-Cola said to be the front runner with a £3bn (US$4bn) offer.
According to a report by Reuters in March, the most enticing asset up for sale is GSK’s 72.5% stake in its Indian subsidiary GlaxoSmithKline Consumer Healthcare. The sources said the stake was worth $3.1 billion at current market prices but GSK wanted a premium in any sale.